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Biodiversity provides a huge source of new chemical entities
that could be useful for the development of new therapies. An
example is venomous animals, which produce venoms that
share common features, such as compositions characterized
by a complex combination of bioactive proteins and peptides
with wide structural diversity. he biological activities of
these compounds are selective and speciic and are currently
dependent on the synergic action of several components.
hus, animal venoms are important tools for carrying out
biochemical, physiological, and pathological studies, as well
as for the development of new biotechnological and pharma-
ceutical products.
he modern approach used to characterize various com-
pounds from animal venoms, using advanced proteomic and
genomic tools, has been denominated “venomics.” Modern
technologies currently available in several research laborato-
ries have allowed scientists to obtain the identiication and
functional-structural characterization of hundreds of toxins
from snakes, scorpions, spiders, anurans, and marine inver-
tebrates, presenting a high diversity of pharmacological activ-
ities. Venomics delineates a scientiic area of high complexity
that is increased by the diversity of venom proteins and the
inluence imposed by age, geographic location, ontogenetic
variation, feeding, and individual intrinsic characteristics
that produce intraspeciic variations.
he study of toxins and their isoforms has allowed for
a better understanding of the toxic mechanisms of enveno-
mation. he identiication/characterization of diferent iso-
forms of venom toxins, along with the search for natural
and synthetic inhibitors, such as monoclonal or polyclonal
antibodies, andmolecules with diferent chemical properties,
such as heparin, clotting factors, and plant extracts, has
increased the possibility of using these agents as more
efective therapeutic alternatives.
More recently, venomics has focused on better under-
standing of the clinical aspects of human envenomation,
the mechanism of action of venoms and their toxins, the
prospection of toxins with biotechnological/pharmaceutical
potential, and the development of novel antivenom serum
and alternative therapies for envenomation.
Among venom toxic components, phospholipases A2, L-
amino acid oxidases, and proteolytic enzymes, which are
classiied as metalloproteases and serine proteases, are able
to disrupt the human haemostatic system through diferent
mechanisms. Nonenzymatic proteins, such as disintegrins
and bradykinin-potentiating peptides (BPPs), and other
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components, such as carbohydrates, lipids, ions, biogenic
amines, nucleotides, and free amino acids, are also compo-
nents of venom.
his special issue presents three revisions and eight
original papers addressing diferent aspects of animal venom
components, their inhibitors, and possible biotechnological
applications. his is relevant considering that snake enven-
omation is still an important public health issue in many
countries, especially tropical ones.
M. B. A. Carvalho et al. present, herein, a mini-review on
phospholipase A2 inhibitors from diferent sources, such as
Brazilian plants and their chemical synthesis. hese authors
report on the antivenom efect of diferent plant extracts
used by traditional communities. hese extracts have been
scientiically validated through the phytochemical identii-
cation and characterization of some isolated inhibitors from
these species, leading to the development of new therapeu-
tic alternatives for envenomation. L. F. M. Izidoro et al.
reviews L-amino acid oxidases isolated from snake venoms,
focusing on their biochemical, biological, and enzymatic
characteristics and discussing the importance of hydrogen
peroxide production, antigenicity, molecular and structural
characteristics, and biotechnological and pharmacological
applications of LAAOs focusing on their antibiotic potential.
Finally, in the third revision paper of this special issue, L.
A. Calderon et al. discussed the continuous search for new
bioactives in order to develop new anticancer drugs. In this
review, the authors describe the potential of proteins and
peptides from snake venoms, which show in vitro and in vivo
cytotoxicity against cancer cells, for the development of more
eicient and safe therapies.
Among the eight original papers, three of them describe
the isolation and biochemical characterization of phospho-
lipases A2 and basic and acidic phospholipase A2 homologs
from the venoms of Bothrops atrox (J. L. Furtado et al.,
2014), Bothrops mattogrossensis (A. A. de Moura et al., 2014),
and Crotalus oreganus abyssus (W. Martins et al., 2014),
which show inlammatory, leishmanicidal, and antitumoral
activities, respectively.
With regard to the search for complementary alternatives
for conventional serum therapies, E. C. De Oliveira et al.
describe the antivenom potential of Manilkara subsericea
extract against Lachesis muta venom, and C. L. S. Guimara˜es
et al. relate the biotechnological application of polyclonal
antibodies produced using alkylated myotoxic phospholi-
pases A2 from Bothrops jararacussu venom with reduced
myotoxic activity.
Finally, three papers report on proteases fromanimal ven-
oms, such as snakes and spiders and their biotechnological
potential. F. D. Torres-Huaco et al. and K. D. Zaqueo et al.
describe the biochemical characterization of two thrombin-
like enzymes (SVTLE) isolated from Lachesis muta and
Bothrops pirajai venoms, respectively. Both enzymes show
blood-clotting activity, indicating a thrombolytic potential.
In contrast, G. Gimenez et al. demonstrate the proteolytic
activity of venom from the social spider Parawixia bistriata
and its possible biotechnological application as an insecticide
against Aedes aegypti.
Research regarding animal venoms generally focuses on
the clinical features of human envenomation, the relation-
ship between structure and function of animal toxins, bio-
prospection of toxins with potential for the development of
therapies, diagnostic kits for human diseases, and alternative
or complementary therapies for envenomation. herefore,
research involving the biologically active components of
animal venoms could result in the direct or indirect use of
components of venoms during the development of synthetic
models in order to obtain new drugs.
hus, understanding the mechanism of action respon-
sible for venoms’ toxic and pharmacologic efects, along
with their biochemical and structural characterizations, is
essential in order for them to be used as biotechnological
prototypes in a range of medical and scientiic areas.
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